{"result": {"id": "65c2460f-795d-4b85-a508-e9978adf5ca1", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**塞来昔布 (Celecoxib)** 是一种选择性COX-2抑制剂，属于非甾体抗炎药（NSAID），主要用于缓解疼痛和炎症，尤其在关节炎等慢性病症中表现出显著疗效。其作用机制是通过选择性抑制环氧化酶-2（COX-2），减少前列腺素的生成，从而减轻疼痛和炎症反应，同时相较于传统NSAIDs（如布洛芬或萘普生），塞来昔布对胃肠道黏膜的刺激更小，因此更适合老年患者或胃肠道风险较高的人群使用。  \n\n在临床应用中，塞来昔布的常见剂量为200毫克，每日两次，半衰期为8至12小时，适用于多种疼痛管理场景，包括骨关节炎、类风湿性关节炎以及急性痛风发作的症状控制。其COX-2选择性特性使其在提供有效镇痛和抗炎效果的同时，降低了胃肠道副作用（如溃疡或出血）的发生率。  \n\n需要注意的是，尽管塞来昔布的胃肠道安全性较高，但仍可能增加心血管事件的风险（如心肌梗死或中风），尤其是在长期或高剂量使用时。因此，临床使用需权衡利弊，并遵循个体化治疗原则。  \n\n综上所述，塞来昔布是一种高效且相对安全的NSAID，特别适合需长期镇痛治疗且胃肠道敏感的患者，但其心血管风险仍需谨慎评估。", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166978, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 272, "prompt_tokens": 209, "total_tokens": 481, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 64}, "prompt_cache_hit_tokens": 64, "prompt_cache_miss_tokens": 145}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or more entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\nLimit the final description length to 500 words.\n\n#######\n-Data-\nEntities: \"塞来昔布\"\nDescription List: [\"A COX-2 inhibitor used for pain relief, particularly in conditions like arthritis\", \"COX-2 selective NSAID (200 mg twice daily) with an 8–12 hour half-life for managing gout symptoms.\\\"\", \"Celecoxib is an NSAID with a lower risk of gastrointestinal side effects, often used in elderly patients>\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_14b70cd0c516df0413c4efe321db37a7b17f16f1de2966c3eb778a1bf53e81b8_v2"}